Application
Antibodies tested include ERα (MC-20): , ERα (H-184): , CBP (A-22): , CBP (C-1): , p/CIP (F2): , p/CIP (M-397): , RIP140 (H-300): and HDAC3 (N-19): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Perissi et al., Cell 2004, 116: 511-526.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing nuclear localization.
Application
Western blot analysis of human recombinant ERα.
IHC
(A) Immunohistochemistry analysis of NLRP3 and ERα in different intestinal tissue sections. (Scale bars, 100µm).
WB
(C) Protein expression levels of ERα and ERβ in the liver tissue.
WB
(E) Protein expression levels of ERα, NLRP3, and Caspase-1 of LMH cells.
WB
(A) Immunoblotting of immunoprecipitation with anti-ERα and anti-GSDMD in Hepa1-6 cells.
WB
(C and D) Western blot analysis of ERα and ERβ.
WB
(E) Protein levels of ERα in the colon tissues. The relative protein expression of ERα was normalized to β-actin.
WB
(C) ERα and ERβ in AFT were located by IHC. Bars: 500 µm.
WB
(A) Protein levels of NLRP3, ASC and Caspase-1 in colon tissues.
WB
(C) Protein expression of NLRP3, ASC, Caspase-1 and ERα in colon tissues.
IHC
(C) ERα and ERβ in AFT were located by IHC. Bars: 500 µm.
WB
(C-E) The protein levels of ERα, NLRP3, ASC and Casp-1p20 in NCM-460 cells following different drug treatments.
WB
(F) The protein levels of ERα and NLRP3 in colon tissues.
WB
(B) The protein level of ERα and NLRP3 in ERα-overexpressing cells